Approval · Notice of Compliance 33937 · 2024
MIEBO: Notice of Compliance 33937
Issued September 4, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33937
- Date
- September 4, 2024
- Company
- Bausch & Lomb Inc.Rochester, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIEBO | 02551403 | Marketed |
Medicinal ingredients
- PERFLUOROHEXYLOCTANE 100 PER